Transfer Pricing Adjustment Dismissed; Focus on Expense Evaluation

The Tribunal dismissed the Revenue's appeal, upholding the deletion of the Transfer Pricing adjustment due to unsuitability of the selected comparable. The Tribunal remanded issues regarding disallowed expenses on freebies to medical practitioners and the dividend distribution tax rate for fresh examination by the Assessing Officer. It emphasized the importance of evaluating expenses in accordance with the Supreme Court's judgment and relevant regulations.

---

---

Issues Involved:
1. Transfer Pricing Adjustment.
2. Disallowance of Expenses on Freebies to Medical Practitioners.
3. Recharacterization of Assessee's Business Activity.
4. Inclusion of Reimbursement of Expenses in Cost Base for Mark-up.
5. Dividend Distribution Tax Rate for Non-Resident Shareholders.

Issue-Wise Detailed Analysis:

1. Transfer Pricing Adjustment:
The primary issue involved the determination of the Arm's Length Price (ALP) for international transactions undertaken by the assessee with its Associate Enterprises (AEs). The Transfer Pricing Officer (TPO) had proposed a Transfer Pricing adjustment of Rs.11,84,06,803 by selecting Lotus Labs as a comparable with an operating margin of 48.78%. However, the Dispute Resolution Panel (DRP) rejected Lotus Labs as a comparable due to significant Related Party Transactions (RPT) exceeding 25% of total revenue. The Tribunal upheld the DRP's decision, noting that the RPT percentage for Lotus Labs was 74.92% for December 2010 and 79.73% for March 2010, making it an unsuitable comparable. Consequently, the TP adjustment was deleted, and the Revenue's appeal on this ground was dismissed.

2. Disallowance of Expenses on Freebies to Medical Practitioners:
The Assessing Officer (AO) disallowed expenses amounting to Rs.1,22,44,326 incurred on travel, conveyance, gifts, and donations to medical practitioners, citing CBDT Circular No.5/2012 and the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 (IMC Regulations). The DRP allowed the deduction for the cost of samples but upheld the disallowance of other expenses. The Tribunal, considering the recent Supreme Court judgment in M/s. Apex Laboratories Pvt. Ltd. v. DCIT, which held that such expenses are not allowable under section 37 of the Act, remanded the matter back to the AO for fresh verification. The Tribunal directed the AO to critically evaluate the nature of expenses in light of the Supreme Court's decision and the IMC Regulations.

3. Recharacterization of Assessee's Business Activity:
The TPO had recharacterized the assessee as a full-fledged Clinical Research Organisation (CRO) instead of a mere coordinator of clinical trial activities. The DRP upheld this recharacterization. However, since the Tribunal dismissed the Revenue's appeal and deleted the TP adjustment, the grounds raised by the assessee challenging the recharacterization were rendered academic and dismissed.

4. Inclusion of Reimbursement of Expenses in Cost Base for Mark-up:
The assessee challenged the inclusion of unrelated expenses reimbursed by the AE and third-party expenses in the cost base for mark-up purposes. Given the deletion of the TP adjustment, this ground also became academic and was dismissed.

5. Dividend Distribution Tax Rate for Non-Resident Shareholders:
The assessee claimed that the tax liability on dividends distributed to non-resident shareholders should be confined to the rate prescribed under the India-Sweden Double Taxation Avoidance Agreement (DTAA). The Tribunal noted that this issue has been referred to a Special Bench and restored the matter to the AO with the direction to follow the decision rendered by the Special Bench in the future.

Conclusion:
The Tribunal dismissed the Revenue's appeal and partly allowed the assessee's appeal for statistical purposes, remanding the issues related to the disallowance of expenses on freebies to medical practitioners and the dividend distribution tax rate for fresh examination and appropriate action by the AO. The Tribunal emphasized the need for a detailed evaluation of the nature of expenses in light of the Supreme Court's judgment and relevant regulations.

---